US20100119564A1 - Guided bone regeneration membrane and manufacturing method thereof - Google Patents

Guided bone regeneration membrane and manufacturing method thereof Download PDF

Info

Publication number
US20100119564A1
US20100119564A1 US12/591,258 US59125809A US2010119564A1 US 20100119564 A1 US20100119564 A1 US 20100119564A1 US 59125809 A US59125809 A US 59125809A US 2010119564 A1 US2010119564 A1 US 2010119564A1
Authority
US
United States
Prior art keywords
bone regeneration
guided bone
regeneration membrane
pla
nonwoven fabric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/591,258
Inventor
Toshihiro Kasuga
Yoshio Ota
Takashi Wakita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yabashi Industries Co Ltd
Nagoya Institute of Technology NUC
Yamahachi Dental Mfg Co
Original Assignee
Yabashi Industries Co Ltd
Nagoya Institute of Technology NUC
Yamahachi Dental Mfg Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yabashi Industries Co Ltd, Nagoya Institute of Technology NUC, Yamahachi Dental Mfg Co filed Critical Yabashi Industries Co Ltd
Assigned to YABASHI INDUSTRIES CO., LTD, NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY, YAMAHACHI DENTAL MFG., CO. reassignment YABASHI INDUSTRIES CO., LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KASUGA, TOSHIHIRO, OTA, YOSHIO, WAKITA, TAKASHI
Publication of US20100119564A1 publication Critical patent/US20100119564A1/en
Priority to US13/592,072 priority Critical patent/US20120315319A1/en
Priority to US14/270,137 priority patent/US10092650B2/en
Priority to US16/119,601 priority patent/US10159737B1/en
Priority to US16/227,582 priority patent/US10814000B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/128Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Definitions

  • the present invention relates to a guided bone regeneration membrane and a manufacturing method thereof.
  • the guided bone regeneration membrane is used in a guided bone regeneration (GBR) technique which is one of techniques for repairing bone defects and which is widely used in the field of oral surgery and maxillofacial surgery.
  • GLR guided bone regeneration
  • Guided bone regeneration membranes are masking membranes that cover bone defect areas so as to prevent invasion of non-osteogenesis-contributed cells and tissues into the bone defect areas and to allow the bone to reconstruct by taking full advantage of self-regenerative power thereof.
  • Guided bone regeneration techniques using these membranes cure bone defects by using a healing potential which the living body inherently has. The techniques are not complicated in their operative procedures and have given many satisfactory outcomes in oral surgery.
  • the guided bone regeneration membranes are broadly grouped under non-bioresorbable membranes and bioresorbable membranes.
  • a polytetrafluoroethylene expanded polytetrafluoroethylene; ePTEF
  • ePTEF expanded polytetrafluoroethylene
  • This material places a not-so light burden on a patient, because it is not bioresorbable and thereby needs a secondary operation for the removal of the membrane after the target bone defect area is repaired.
  • bioresorbable guided bone regeneration membranes that are bioresorbable can avoid the surgical stress caused by the secondary operation.
  • exemplary materials for such bioresorbable guided bone regeneration membranes include poly(lactic acid)s as bioresorbable synthetic polyesters; and copoly(lactic acid/glycolic acid)s; and collagens and fasciae each of biological origin.
  • Such bioresorbable guided bone regeneration membranes have been recently investigated and developed heavily, and some of them have already been commercialized.
  • a bone regeneration membrane including a composite of a bioresorbable polymer with tricalcium phosphate or hydroxyapatite and having micropores Japanese Unexamined Patent Application Publication (JP-A) No. H06 (1994)-319794
  • a protective membrane including a felt made from a bioresorbable material Japanese Unexamined Patent Application Publication (JP-A) No. H07 (1995)-265337; and Japanese Unexamined Patent Application Publication (JP-A) No.
  • a multilayer membrane including a sponge-like collagen matrix layer and a relatively impermeable barrier layer Japanese Unexamined Patent Application Publication (Translation of PCT Application) (JP-A) No. 2001-519210)
  • a bioresorbable tissue regeneration membrane for dental use which has a porous sheet-like structure including a polymer blend containing two or more different bioresorbable polymers
  • Japanese Unexamined Patent Application Publication (JP-A) No. 2002-85547 Japanese Unexamined Patent Application Publication (JP-A) No. 2002-85547
  • a resorbable flexible implant in the form of a continuous micro-porous sheet Japanese Unexamined Patent Application Publication (Translation of PCT Application) (JP-A) No. 2003-517326
  • a biocompatible membrane prepared by three-dimensional powder sinter molding through application of laser light to a biodegradable resin powder Japanese Unexamined Patent Application Publication (JP-A) No. 2006-187303).
  • the present invention provides, in an embodiment, a guided bone regeneration membrane which has a bi-layered structure including a first nonwoven fabric layer and a second nonwoven fabric layer.
  • the first nonwoven fabric layer contains a silicon-releasable calcium carbonate (Si—CaCO 3 ) and a biodegradable resin, represented by a poly(lactic acid) (PLA), as principal components (hereinafter referred to as “Si—CaCO 3 /PLA layer”).
  • the second nonwoven fabric layer contains biodegradable resin, representedbya PLA, as a principal component (hereinafter referred to as “PLA layer”).
  • PLA poly(lactic acid)
  • the Si—CaCO 3 /PLA layer may be further coated with an apatite.
  • the PLA layer has the function of preventing the invasion of soft tissues, and the apatite-coated Si—CaCO 3 /PLA layer has the function of improving cellular affinity and/or osteogenic ability.
  • a technique of manufacturing a nonwoven fabric through electrospinning is adopted to the manufacturing of such a guided bone regeneration membrane. This provides an easy manufacturing of a membrane that has continuous pores for supplying nutrients to cells and shows improved fitting ability to an affected area.
  • Such a bioresorbable apatite that improves cellular initial adhesion can be easily applied to the Si—CaCO 3 /PLA layer by soaking the layer in a simulated body fluid (SEF).
  • SEF simulated body fluid
  • the guided bone regeneration membrane according to the present invention shows high cellular growth ability in cellular affinity tests using osteoblastic cells (MC3T3-E1 cells) and is expected as a bioresorbable guided bone regeneration membrane that excels in bone reconstruction ability.
  • the method according to the present invention can easily and efficiently manufacture a guided bone regeneration membrane having the above possibility.
  • FIG. 1 is a scanning electron micrograph (SEM photograph) of a PLA layer surface of a guided bone regeneration membrane prepared in Example 1;
  • FIG. 2 is a scanning electron micrograph of a Si—CaCO 3 /PLA layer surface of the guided bone regeneration membrane prepared in Example 1;
  • FIG. 3 is a scanning electron micrograph of a surface of a PLA layer prepared in Example 2;
  • FIG. 4 is a scanning electron micrograph of a surface of a Si—CaCO 3 /PLA layer prepared in Example 2;
  • FIG. 5 is a scanning electron micrograph of fibers configuring the Si—CaCO 3 /PLA layer prepared in Example 2;
  • FIG. 6 is a scanning electron micrograph of fibers configuring the Si—CaCO 3 /PLA layer after soaking a composite membrane prepared in Example 2 in 1.5 SBF;
  • FIG. 7 depicts X-ray diffraction patterns of the composite membrane prepared in Example 2, before and after soaking in 1.5SBF;
  • FIG. 8 is a graph for the evaluation of the cellular affinity of the Si—CaCO 3 /PLA layer and PLA layer prepared in Example 2.
  • such a guided bone regeneration membrane can be manufactured through the steps of electrospinning and soaking in a simulated body fluid (SBF).
  • a positive high voltage is applied to a polymer solution, and the resulting polymer solution is sprayed as fibers to a negatively charged collector.
  • a spinning solution for the formation of the PLA layer is prepared by dissolving a poly(lactic acid) in chloroform (CHCl 3 ) or dichloromethane (DCM).
  • the PLA spinning solution preferably has a poly (lactic acid) concentration of from 4 to 12 percent by weight for easy spinning.
  • the poly(lactic acid) generally has a molecular weight of from about 20 ⁇ 10 4 to about 30 ⁇ 10 4 .
  • the PLA spinning solution may further contain dimethylformamide (DMF) and/or methanol (CH 3 OH) in an amount up to about 50 percent by weight relative to the amount of CHCl 3 or DCM.
  • Si—CaCO 3 /PLA spinning solution Another spinning solution for the formation of the Si—CaCO 3 /PLA layer (Si—CaCO 3 /PLA spinning solution) is prepared by adding Si—CaCO 3 to the PLA spinning solution.
  • the Si—CaCO 3 is preferably added to the solution so that the Si—CaCO 3 /PLA layer has a Si—CaCO 3 content of from 40 to 60 percent by weight. This allows an apatite to deposit efficiently on Si—CaCO 3 /PLA fibers in the SBF soaking step.
  • a Si—CaCO 3 /PLA spinning solution can be prepared by kneading a poly (lactic acid) and Si—CaCO 3 in predetermined proportions using a heating kneader to give a composite, and dissolving the composite in a solvent.
  • the Si—CaCO 3 may be prepared, for example, by the method described in Japanese Patent Application No. 2006-285429 (corresponding to Japanese Unexamined Patent Application Publication (JP-A) No. 2008-100878).
  • the PLA layer preferably contains a poly(lactic acid) (PLA) alone or a copolymer between a poly (lactic acid) and a poly(glycolic acid) (PGA) (copoly(lactic acid/glycolic acid))
  • PLA poly(lactic acid)
  • PGA poly(glycolic acid)
  • Exemplary other biodegradable resins usable herein include synthetic polymers such as polyethylene glycols (PEGS), polycaprolactones (PCLs), as well as copolymers among lactic acid, glycolic acid, ethylene glycol, and/or caprolactone; and natural polymers such as fibrin, collagens, alginic acids, hyaluronic acids, chitins, and chitosans.
  • the Si—CaCO 3 /PLA layer and the PLA layer may further contain inorganic substances that are usable without biological problems.
  • inorganic substances include tricalcium phosphate, calcium sulfate, sodium phosphate, sodium hydrogenphosphate, calcium hydrogenphosphate, octacalcium phosphate, tetracalcium phosphate, calcium pyrophosphate, and calcium chloride.
  • each of the PLA layer spinning solution and the Si—CaCO 3 /PLA spinning solution is charged and sprayed from a nozzle, converted into fibers in an electric field while evaporating the solvent, the charged fibers are jetted toward a collector on a negative electrode and form a thin layer of fibers on the collector.
  • a desired guided bone regeneration membrane can be prepared by changing spinning conditions such as the concentration, solvent type, and supply speed (feed rate) of the spinning solution; spinning time; applied voltage; and distance between the nozzle and the collector.
  • the prepared nonwoven fabrics may be pressed so as to be compacted or to have a desired thickness.
  • a guided bone regeneration membrane having a bi-layered structure is configured by spraying the PLA spinning solution to form a PLA layer, and thereafter spraying the Si—CaCO 3 /PLA spinning solution to form a Si—CaCO 3 /PLA layer on the PLA layer; or by preparing a PLA nonwoven fabric and a Si—CaCO 3 /PLA nonwoven fabric independently, and combining the two nonwoven fabrics.
  • the guided bone regeneration membrane having a bi-layered structure is cut to a desired size and soaked in a simulated body fluid (SBF) or a solution with 1.5 times higher concentration of inorganic ions compared to SBF (1.5SBF) at about 37° C.
  • SBF simulated body fluid
  • the SBF soaking can be performed even after the combining (or laminating) the two layers. Even in this case, the apatite deposits substantially not on the PLA layer but selectively on the Si—CaCO 3 /PLA layer.
  • Silicon-releasable calcium carbonate (Si—CaCO 3 ): Vaterite having a silicon content of 2.9 percent by weight and prepared by using slaked lime (Microstar T; purity 96% or more; Yabashi Industries Co., Ltd., Japan), methanol (analytical grade reagent; purity 99.8% or more; Kishida Chemical Co., Ltd., Japan), ⁇ -aminopropyltriethoxysilane (TSL 8331; purity 98% or more; GE Toshiba Silicones Co., Ltd., Japan), and carbon dioxide gas (high-purity liquefied carbon dioxide gas; purity 99.9%; Taiyo Kagaku Kogyo K.K.)
  • PVA Poly(lactic acid)
  • PURASORB Poly(L-lactide)
  • molecular weight 20 ⁇ 10 4 to 30 ⁇ 10 4
  • N,N-Dimethylformamide (DMF) Analytical grade reagent, purity 99.5% or more, Kishida Chemical Co., Ltd., Japan
  • DMF N,N-Dimethylformamide
  • a PLA spinning solution having a PLA concentration of 6.8 percent by weight was prepared by blending 10 g of PLA, 110 g of CHCl 3 , and 27.5 g of DMF.
  • a Si—CaCO 3 /PLA spinning solution having a Si—CaCO 3 concentration of 7.5 percent by weight and a PLA concentration of 5.0 percent by weight was prepared by blending 15 g of Si—CaCO 3 , 10 g of PLA, 140 g of CHCl 3 , and 35 g of DMF.
  • a guided bone regeneration membrane having a bi-layered structure of nonwoven fabrics was manufactured through electrospinning.
  • Spinning solution feed rate about 0.1 ml/min.
  • applied voltage 15 kV
  • distance between the nozzle and collector 10 cm
  • nozzle laterally moves in a width of 3 to 4 cm at a rate of 15 cm/min
  • conveyor-type collector Conveyor speed: 5 to 6 m/min
  • spinning time about 170 minutes
  • Spinning solution feed rate about 0.16 ml/min
  • applied voltage 20 kV
  • distance between the nozzle and collector 10 cm
  • nozzle laterally moves in a width of 3 to 4 cm at a rate of 15 cm/min
  • conveyor-type collector Conveyor speed: 5 to 6 m/min
  • spinning time about 130 minutes
  • the microstructure of the prepared PLA layer (side for preventing soft tissue invasion) is shown in the scanning electron microscope (SEM) photograph of FIG. 1 .
  • the microstructure of the Si—CaCO 3 /PLA layer (bone regeneration side) is shown in the scanning electronmicrograph of FIG. 2 , demonstrating that Si—CaCO 3 particles are attached to PLA fibers.
  • a spinning solution having a PLA concentration of 9.0 percent by weight was prepared by blending 9 g of PLA and 91 g of CHCl 3 , and using this spinning solution, a PLA layer was prepared through electrospinning.
  • Spinning solution feed rate 0.05 ml/min, applied voltage: 20 kV, distance between the nozzle and collector: 15 cm, nozzle: fixed, plate collector: fixed, spinning time: 60 minutes
  • PLA and Si—CaCO 3 were kneaded in a heating kneader at 200° C. for 15 minutes to give a Si—CaCO 3 /PLA composite containing 60 percent by weight of Si—CaCO 3 .
  • a spinning solution having a Si—CaCO 3 concentration of 13.0 percent by weight and a PLA concentration of 8.7 percent by weight was prepared by blending 25 g of the Si—CaCO 3 /PLA composite and 90 g of CHCl 3 , and using this spinning solution, a Si—CaCO 3 /PLA layer was prepared through electrospinning.
  • Spinning solution feed rate 0.05 ml/min
  • applied voltage is 20 kV
  • distance between the nozzle and collector 15 cm
  • nozzle fixed
  • plate collector fixed
  • spinning time 30 minutes
  • the two nonwoven fabrics prepared by the above procedures were each cut to a desired size and affixed or combined with each other to give one membrane.
  • the PLA layer was laid over the Si—CaCO 3 /PLA layer, and a stainless steel mesh (40-mesh) was laid over the PLA layer.
  • a plate heated at 150° C. to 160° C. was placed on the stainless steel mesh and pressed under a suitable pressure for about 10 seconds to give the combined membrane (composite membrane).
  • FIG. 3 and FIG. 4 The scanning electron micrographs of fibers configuring the Si—CaCO 3 /PLA layer is shown in FIG. 5 , demonstrating that Si—CaCO 3 particles are attached to PLA fibers.
  • the Si—CaCO 3 /PLA layer surface of the resulting composite membrane was brought into contact with 1.5SBF at 37° C. for one day.
  • the scanning electron micrograph of fibers on the side in contact with 1.5SBF is shown in FIG. 6 , demonstrating that a substance quite different from Si—CaCO 3 covers the surface of fibers, as compared to FIG. 5 .
  • the X-ray diffraction patterns before and after soaking in 1.5SBF are shown in FIG. 7 , indicating that peaks of apatite appear after the soaking.
  • FIG. 8 shows how cellular numbers (in terms of cellular numbers per 1 cm 2 ) vary after the inoculation of osteoblastic cells on the apatite-coated Si—CaCO 3 /PLA layer surface (Si-composite), on the PLA layer surface (PLA), and on a control (Thermanox: plastic disc for cell culture which has been treated on its surface).
  • the data in FIG. 8 demonstrate that the layer including PLA in combination with a novel mechanism gives higher growth capability to osteoblasts, and the resulting guided bone regeneration membrane is expected as a bioresorbable guided bone regeneration membrane that excels in bone reconstruction ability.
  • ⁇ -MEM containing 10% fetal bovine serum
  • Cell counting method The measurement was performed using the Cell Counting Kit-8 (cellular growth/cellular toxicity analytical reagent; Dojindo Laboratories) in accordance with the protocol attached to the reagent.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Disclosed is a guided bone regeneration membrane including a novel mechanism that effectively induces a bone reconstruction ability. The mechanism is provided by forming a bi-layered structure of a first nonwoven fabric layer containing a silicon-releasable calcium carbonate and a poly(lactic acid) as principal components and a second nonwoven fabric layer containing a poly(lactic acid) as a principal component; and coating the first nonwoven fabric layer with an apatite. The guided bone regeneration membrane is available by using a nonwoven fabric manufacturing technique through electrospinning and a simulated body fluid soaking technique.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a guided bone regeneration membrane and a manufacturing method thereof. The guided bone regeneration membrane is used in a guided bone regeneration (GBR) technique which is one of techniques for repairing bone defects and which is widely used in the field of oral surgery and maxillofacial surgery.
  • RELATED ART OF THE INVENTION
  • Guided bone regeneration membranes are masking membranes that cover bone defect areas so as to prevent invasion of non-osteogenesis-contributed cells and tissues into the bone defect areas and to allow the bone to reconstruct by taking full advantage of self-regenerative power thereof. Guided bone regeneration techniques using these membranes cure bone defects by using a healing potential which the living body inherently has. The techniques are not complicated in their operative procedures and have given many satisfactory outcomes in oral surgery.
  • The guided bone regeneration membranes are broadly grouped under non-bioresorbable membranes and bioresorbable membranes. A polytetrafluoroethylene (expanded polytetrafluoroethylene; ePTEF) has been practically used as a material for a non-bioresorbable membrane, from which good clinical data have been obtained. This material, however, places a not-so light burden on a patient, because it is not bioresorbable and thereby needs a secondary operation for the removal of the membrane after the target bone defect area is repaired. In addition, it is difficult to adopt this material to a large defect area, because the material is bioinert (non-bioresorbable). In contrast, use of guided bone regeneration membranes that are bioresorbable can avoid the surgical stress caused by the secondary operation. Exemplary materials for such bioresorbable guided bone regeneration membranes include poly(lactic acid)s as bioresorbable synthetic polyesters; and copoly(lactic acid/glycolic acid)s; and collagens and fasciae each of biological origin. Such bioresorbable guided bone regeneration membranes have been recently investigated and developed heavily, and some of them have already been commercialized. Typically, there have been proposed a wide variety of guided bone regeneration membranes and manufacturing methods thereof; such as a bone regeneration membrane including a composite of a bioresorbable polymer with tricalcium phosphate or hydroxyapatite and having micropores (Japanese Unexamined Patent Application Publication (JP-A) No. H06 (1994)-319794); a protective membrane including a felt made from a bioresorbable material (Japanese Unexamined Patent Application Publication (JP-A) No. H07 (1995)-265337; and Japanese Unexamined Patent Application Publication (JP-A) No. 2004-105754); a multilayer membrane including a sponge-like collagen matrix layer and a relatively impermeable barrier layer (Japanese Unexamined Patent Application Publication (Translation of PCT Application) (JP-A) No. 2001-519210); a bioresorbable tissue regeneration membrane for dental use, which has a porous sheet-like structure including a polymer blend containing two or more different bioresorbable polymers (Japanese Unexamined Patent Application Publication (JP-A) No. 2002-85547); a resorbable flexible implant in the form of a continuous micro-porous sheet (Japanese Unexamined Patent Application Publication (Translation of PCT Application) (JP-A) No. 2003-517326); and a biocompatible membrane prepared by three-dimensional powder sinter molding through application of laser light to a biodegradable resin powder (Japanese Unexamined Patent Application Publication (JP-A) No. 2006-187303).
  • In particular, oral or maxillary bone defects should be desirably cured as soon as possible, because it is very important to maintain and ensure mastication for the health maintenance in a super-graying society. To improve osteogenic ability, there have been attempts to incorporate to a bioresorbable membrane a factor such as an osteogenesis inducer (Japanese Unexamined Patent Application Publication (JP-A) No. H06 (1994)-319794), a growth factor or a bone morphogenic protein (Japanese Unexamined Patent Application Publication (Translation of PCT Application) (JP-A) No. 2001-519210; and Japanese Unexamined Patent Application Publication (JP-A) No. 2006-187303). However, it is difficult to handle these factors. Accordingly, demands have been made to develop a bioresorbable guided bone regeneration membrane having superior bone reconstruction ability to allow the bone to self-regenerate more reliably and more rapidly.
  • In view of recent trends of researches and technologies for bio-related materials, the main stream of researches has been shifted from a materials design for the bonding of a material with the bone to a materials design for the regeneration of a real bone; in these researches, the role of silicon in osteogenesis has been received attention; and there have been designed a variety of materials containing silicon (TSURU Kanji, OGAWA Tetsuro, and OGUSHI Hajime, “Recent Trends of Bioceramics Research, Technology and Standardization”, Ceramics Japan, 41, 549-553 (2006)). For example, there has been reported that the controlled release of silicon genetically acts on cells to promote osteogenesis (H. Maeda, T. Kasuga, and L. L. Hench, “Preparation of Poly(L-lactic acid)-Polysiloxane-Calcium Carbonate Hybrid Membranes for Guided Bone Regeneration”, Biomaterials, 27, 1216-1222 (2006)). Independently, when composites of a poly(lactic acid) with one of three calcium carbonates (calcite, aragonite, and vaterite) are soaked in a simulated body fluid (SBF), the composite of a poly(lactic acid) with vaterite forms a bone-like apatite within a shortest time among the three composites (H. Maeda, T. Kasuga, M. Nogami, and Y Ota, “Preparation of Calcium Carbonate Composite and Their Apatite-Forming Ability in Simulated Body Fluid”, J. Ceram. Soc. Japan, 112, S804-808 (2004)). These findings demonstrate that the use of vaterite which gradually releases silicon is believed to be a key to provide a guided bone regeneration membrane that gives rapid bone reconstruction.
  • SUMMARY OF THE INVENTION
  • An object of the present invention is to provide a bioresorbable guided bone regeneration membrane that includes a novel mechanism effectively inducing a bone reconstruction ability. Another object of the present invention is to provide a method for manufacturing a guided bone regeneration membrane of high performance (achieving rapid bone reconstruction) in an inexpensive and industrially advantageous manner.
  • The present invention provides, in an embodiment, a guided bone regeneration membrane which has a bi-layered structure including a first nonwoven fabric layer and a second nonwoven fabric layer. The first nonwoven fabric layer contains a silicon-releasable calcium carbonate (Si—CaCO3) and a biodegradable resin, represented by a poly(lactic acid) (PLA), as principal components (hereinafter referred to as “Si—CaCO3/PLA layer”). The second nonwoven fabric layer contains biodegradable resin, representedbya PLA, as a principal component (hereinafter referred to as “PLA layer”). In the guided bone regeneration membrane, the Si—CaCO3/PLA layer may be further coated with an apatite.
  • The PLA layer has the function of preventing the invasion of soft tissues, and the apatite-coated Si—CaCO3/PLA layer has the function of improving cellular affinity and/or osteogenic ability. In another embodiment, a technique of manufacturing a nonwoven fabric through electrospinning is adopted to the manufacturing of such a guided bone regeneration membrane. This provides an easy manufacturing of a membrane that has continuous pores for supplying nutrients to cells and shows improved fitting ability to an affected area. Such a bioresorbable apatite that improves cellular initial adhesion can be easily applied to the Si—CaCO3/PLA layer by soaking the layer in a simulated body fluid (SEF).
  • The guided bone regeneration membrane according to the present invention shows high cellular growth ability in cellular affinity tests using osteoblastic cells (MC3T3-E1 cells) and is expected as a bioresorbable guided bone regeneration membrane that excels in bone reconstruction ability. The method according to the present invention can easily and efficiently manufacture a guided bone regeneration membrane having the above possibility.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Other objects, features and advantages of the present invention will be understood more fully from the following detailed description made with reference to the accompanying drawings. In the drawings:
  • FIG. 1 is a scanning electron micrograph (SEM photograph) of a PLA layer surface of a guided bone regeneration membrane prepared in Example 1;
  • FIG. 2 is a scanning electron micrograph of a Si—CaCO3/PLA layer surface of the guided bone regeneration membrane prepared in Example 1;
  • FIG. 3 is a scanning electron micrograph of a surface of a PLA layer prepared in Example 2;
  • FIG. 4 is a scanning electron micrograph of a surface of a Si—CaCO3/PLA layer prepared in Example 2;
  • FIG. 5 is a scanning electron micrograph of fibers configuring the Si—CaCO3/PLA layer prepared in Example 2;
  • FIG. 6 is a scanning electron micrograph of fibers configuring the Si—CaCO3/PLA layer after soaking a composite membrane prepared in Example 2 in 1.5 SBF;
  • FIG. 7 depicts X-ray diffraction patterns of the composite membrane prepared in Example 2, before and after soaking in 1.5SBF; and
  • FIG. 8 is a graph for the evaluation of the cellular affinity of the Si—CaCO3/PLA layer and PLA layer prepared in Example 2.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The present invention will be described further with reference to various embodiments in the drawings.
  • First Embodiment
  • According to a preferred embodiment of the present invention, such a guided bone regeneration membrane can be manufactured through the steps of electrospinning and soaking in a simulated body fluid (SBF). In the electrospinning step, a positive high voltage is applied to a polymer solution, and the resulting polymer solution is sprayed as fibers to a negatively charged collector.
  • A spinning solution for the formation of the PLA layer (PLA spinning solution) is prepared by dissolving a poly(lactic acid) in chloroform (CHCl3) or dichloromethane (DCM). The PLA spinning solution preferably has a poly (lactic acid) concentration of from 4 to 12 percent by weight for easy spinning. In this connection, the poly(lactic acid) generally has a molecular weight of from about 20×104 to about 30×104. For maintaining conditions for satisfactory spinning, the PLA spinning solution may further contain dimethylformamide (DMF) and/or methanol (CH3OH) in an amount up to about 50 percent by weight relative to the amount of CHCl3 or DCM. Another spinning solution for the formation of the Si—CaCO3/PLA layer (Si—CaCO3/PLA spinning solution) is prepared by adding Si—CaCO3 to the PLA spinning solution. The Si—CaCO3 is preferably added to the solution so that the Si—CaCO3/PLA layer has a Si—CaCO3 content of from 40 to 60 percent by weight. This allows an apatite to deposit efficiently on Si—CaCO3/PLA fibers in the SBF soaking step. Alternatively, a Si—CaCO3/PLA spinning solution can be prepared by kneading a poly (lactic acid) and Si—CaCO3 in predetermined proportions using a heating kneader to give a composite, and dissolving the composite in a solvent. The Si—CaCO3 may be prepared, for example, by the method described in Japanese Patent Application No. 2006-285429 (corresponding to Japanese Unexamined Patent Application Publication (JP-A) No. 2008-100878). The PLA layer preferably contains a poly(lactic acid) (PLA) alone or a copolymer between a poly (lactic acid) and a poly(glycolic acid) (PGA) (copoly(lactic acid/glycolic acid)) Exemplary other biodegradable resins usable herein include synthetic polymers such as polyethylene glycols (PEGS), polycaprolactones (PCLs), as well as copolymers among lactic acid, glycolic acid, ethylene glycol, and/or caprolactone; and natural polymers such as fibrin, collagens, alginic acids, hyaluronic acids, chitins, and chitosans. Each of these can be used instead of the PLA component in the Si—CaCO3/PLA layer. The Si—CaCO3/PLA layer and the PLA layer may further contain inorganic substances that are usable without biological problems. Examples of such inorganic substances include tricalcium phosphate, calcium sulfate, sodium phosphate, sodium hydrogenphosphate, calcium hydrogenphosphate, octacalcium phosphate, tetracalcium phosphate, calcium pyrophosphate, and calcium chloride.
  • Using an electrospinning apparatus, each of the PLA layer spinning solution and the Si—CaCO3/PLA spinning solution is charged and sprayed from a nozzle, converted into fibers in an electric field while evaporating the solvent, the charged fibers are jetted toward a collector on a negative electrode and form a thin layer of fibers on the collector. A desired guided bone regeneration membrane can be prepared by changing spinning conditions such as the concentration, solvent type, and supply speed (feed rate) of the spinning solution; spinning time; applied voltage; and distance between the nozzle and the collector. The prepared nonwoven fabrics may be pressed so as to be compacted or to have a desired thickness. A guided bone regeneration membrane having a bi-layered structure is configured by spraying the PLA spinning solution to form a PLA layer, and thereafter spraying the Si—CaCO3/PLA spinning solution to form a Si—CaCO3/PLA layer on the PLA layer; or by preparing a PLA nonwoven fabric and a Si—CaCO3/PLA nonwoven fabric independently, and combining the two nonwoven fabrics. The guided bone regeneration membrane having a bi-layered structure is cut to a desired size and soaked in a simulated body fluid (SBF) or a solution with 1.5 times higher concentration of inorganic ions compared to SBF (1.5SBF) at about 37° C. for a predetermined time to precipitate an apatite on the Si—CaCO3/PLA layer. This gives a bioresorbable guided bone regeneration membrane including a novel mechanism that effectively induces the bone reconstruction ability. The SBF soaking can be performed even after the combining (or laminating) the two layers. Even in this case, the apatite deposits substantially not on the PLA layer but selectively on the Si—CaCO3/PLA layer. This is because silicon contained in the Si—CaCO3/PLA layer induces nucleation of apatite, and the calcium component dissolves out to abruptly increase the degree of supersaturation of apatite, and the apatite selectively deposits on the surface of the Si—CaCO3/PLA layer; but the surface of the PLA layer is hydrophobic to avoid the deposition of apatite substantially.
  • EXAMPLES
  • Manufacturing methods of guided bone regeneration membranes according to embodiments of the present invention will be illustrated with reference to several examples below. It should be noted, however, that these examples are included merely to aid in the understanding of the present invention and are not to be construed to limit the scope of the present invention.
  • Raw materials used in the examples are as follows.
  • Silicon-releasable calcium carbonate (Si—CaCO3): Vaterite having a silicon content of 2.9 percent by weight and prepared by using slaked lime (Microstar T; purity 96% or more; Yabashi Industries Co., Ltd., Japan), methanol (analytical grade reagent; purity 99.8% or more; Kishida Chemical Co., Ltd., Japan), γ-aminopropyltriethoxysilane (TSL 8331; purity 98% or more; GE Toshiba Silicones Co., Ltd., Japan), and carbon dioxide gas (high-purity liquefied carbon dioxide gas; purity 99.9%; Taiyo Kagaku Kogyo K.K.)
  • Poly(lactic acid) (PLA): PURASORB PL Poly(L-lactide), molecular weight of 20×104 to 30×104, PURAC Biochem
  • Chloroform (CHCl3): Analytical grade reagent, purity 99.0% or more, Kishida Chemical Co., Ltd., Japan
  • N,N-Dimethylformamide (DMF): Analytical grade reagent, purity 99.5% or more, Kishida Chemical Co., Ltd., Japan Example 1
  • A PLA spinning solution having a PLA concentration of 6.8 percent by weight was prepared by blending 10 g of PLA, 110 g of CHCl3, and 27.5 g of DMF. Independently, a Si—CaCO3/PLA spinning solution having a Si—CaCO3 concentration of 7.5 percent by weight and a PLA concentration of 5.0 percent by weight was prepared by blending 15 g of Si—CaCO3, 10 g of PLA, 140 g of CHCl3, and 35 g of DMF. Using the prepared spinning solutions, a guided bone regeneration membrane having a bi-layered structure of nonwoven fabrics was manufactured through electrospinning.
  • [PLA Layer Preparation Conditions]
  • Spinning solution feed rate: about 0.1 ml/min., applied voltage: 15 kV, distance between the nozzle and collector: 10 cm, nozzle: laterally moves in a width of 3 to 4 cm at a rate of 15 cm/min, conveyor-type collector (conveyor speed: 5 to 6 m/min), spinning time: about 170 minutes
  • [Si—CaCO3/PLA Layer Preparation Conditions]
  • Spinning solution feed rate: about 0.16 ml/min, applied voltage: 20 kV, distance between the nozzle and collector: 10 cm, nozzle: laterally moves in a width of 3 to 4 cm at a rate of 15 cm/min, conveyor-type collector (conveyor speed: 5 to 6 m/min), spinning time: about 130 minutes
  • The microstructure of the prepared PLA layer (side for preventing soft tissue invasion) is shown in the scanning electron microscope (SEM) photograph of FIG. 1. The microstructure of the Si—CaCO3/PLA layer (bone regeneration side) is shown in the scanning electronmicrograph of FIG. 2, demonstrating that Si—CaCO3 particles are attached to PLA fibers.
  • Example 2
  • A spinning solution having a PLA concentration of 9.0 percent by weight was prepared by blending 9 g of PLA and 91 g of CHCl3, and using this spinning solution, a PLA layer was prepared through electrospinning.
  • [PLA Layer Preparation Conditions]
  • Spinning solution feed rate: 0.05 ml/min, applied voltage: 20 kV, distance between the nozzle and collector: 15 cm, nozzle: fixed, plate collector: fixed, spinning time: 60 minutes
  • Independently, PLA and Si—CaCO3 were kneaded in a heating kneader at 200° C. for 15 minutes to give a Si—CaCO3/PLA composite containing 60 percent by weight of Si—CaCO3. A spinning solution having a Si—CaCO3 concentration of 13.0 percent by weight and a PLA concentration of 8.7 percent by weight was prepared by blending 25 g of the Si—CaCO3/PLA composite and 90 g of CHCl3, and using this spinning solution, a Si—CaCO3/PLA layer was prepared through electrospinning.
  • [Si—CaCO3/PLA Layer Preparation Conditions]
  • Spinning solution feed rate: 0.05 ml/min, applied voltage: is 20 kV, distance between the nozzle and collector: 15 cm, nozzle: fixed, plate collector: fixed, spinning time: 30 minutes
  • The two nonwoven fabrics prepared by the above procedures were each cut to a desired size and affixed or combined with each other to give one membrane. Specifically, the PLA layer was laid over the Si—CaCO3/PLA layer, and a stainless steel mesh (40-mesh) was laid over the PLA layer. A plate heated at 150° C. to 160° C. was placed on the stainless steel mesh and pressed under a suitable pressure for about 10 seconds to give the combined membrane (composite membrane). The scanning electron micrographs of the PLA layer surface and of the Si—CaCO3/PLA layer surface are shown in FIG. 3 and FIG. 4, respectively. The scanning electron micrograph of fibers configuring the Si—CaCO3/PLA layer is shown in FIG. 5, demonstrating that Si—CaCO3 particles are attached to PLA fibers.
  • The Si—CaCO3/PLA layer surface of the resulting composite membrane was brought into contact with 1.5SBF at 37° C. for one day. The scanning electron micrograph of fibers on the side in contact with 1.5SBF is shown in FIG. 6, demonstrating that a substance quite different from Si—CaCO3 covers the surface of fibers, as compared to FIG. 5. The X-ray diffraction patterns before and after soaking in 1.5SBF are shown in FIG. 7, indicating that peaks of apatite appear after the soaking. These results demonstrate that the Si—CaCO3/PLA layer surface is coated with apatite.
  • FIG. 8 shows how cellular numbers (in terms of cellular numbers per 1 cm2) vary after the inoculation of osteoblastic cells on the apatite-coated Si—CaCO3/PLA layer surface (Si-composite), on the PLA layer surface (PLA), and on a control (Thermanox: plastic disc for cell culture which has been treated on its surface). The data in FIG. 8 demonstrate that the layer including PLA in combination with a novel mechanism gives higher growth capability to osteoblasts, and the resulting guided bone regeneration membrane is expected as a bioresorbable guided bone regeneration membrane that excels in bone reconstruction ability.
  • Experimental Conditions
  • Cultivation using 24-well plate
  • Cell type; murine osteoblastic cells (MC3T3-E1 cells: Riken Institute of Physical and Chemical Research)
  • Cellular inoculation number: 1×104 cells/well
  • Medium: α-MEM (containing 10% fetal bovine serum)
  • Medium exchange: on the day following the inoculation, thereafter every other day
  • Cell counting method: The measurement was performed using the Cell Counting Kit-8 (cellular growth/cellular toxicity analytical reagent; Dojindo Laboratories) in accordance with the protocol attached to the reagent.
  • While the above description is of the preferred embodiments of the present invention, it should be appreciated that the invention may be modified, altered, or varied without deviating from the scope and fair meaning of the following claims.

Claims (12)

1. A guided bone regeneration membrane comprising a bi-layered structure including a first nonwoven fabric layer and a second nonwoven fabric layer, the first nonwoven fabric layer containing a silicon-releasable calcium carbonate and a biodegradable resin as principal components, and the second nonwoven fabric layer containing a biodegradable resin as a principal component.
2. The guided bone regeneration membrane according to claim 1, wherein the surface of the first nonwoven fabric layer containing a silicon-releasable calcium carbonate and a biodegradable resin as principal components is coated with an apatite, the apatite having been deposited through soaking in a simulated body fluid.
3. The guided bone regeneration membrane according to claim 2, wherein the biodegradable resin is a poly(lactic acid).
4. The guided bone regeneration membrane according to claim 2, wherein the biodegradable resin is a poly(lactic acid).
5. The guided bone regeneration membrane according to claim 1, wherein the silicon-releasable calcium carbonate is of vaterite phase.
6. The guided bone regeneration membrane according to claim 2, wherein the silicon-releasable calcium carbonate is of vaterite phase.
7. The guided bone regeneration membrane according to claim 3, wherein the silicon-releasable calcium carbonate is of vaterite phase.
8. The guided bone regeneration membrane according to claim 4, wherein the silicon-releasable calcium carbonate is of vaterite phase.
9. A method for manufacturing a guided bone regeneration membrane, the method comprising the steps of:
forming a first nonwoven fabric through electrospinning, the first nonwoven fabric containing a silicon-releasable calcium carbonate and a biodegradable resin as principal components; and
forming a second nonwoven fabric through electrospinning, the second nonwoven fabric containing a biodegradable resin as a principal component.
10. The method for manufacturing a guided bone regeneration membrane, according to claim 9, wherein the biodegradable resin is a polylactic acid).
11. The method for manufacturing a guided bone regeneration membrane, according to claim 9, wherein the silicon-releasable calcium carbonate is of a vaterite phase.
12. The method for manufacturing a guided bone regeneration membrane, according to claim 10, wherein the silicon-releasable calcium carbonate is of a vaterite phase.
US12/591,258 2007-09-06 2009-11-13 Guided bone regeneration membrane and manufacturing method thereof Abandoned US20100119564A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/592,072 US20120315319A1 (en) 2007-09-06 2012-08-22 Guided bone regeneration membrane and manufacturing method thereof
US14/270,137 US10092650B2 (en) 2007-09-06 2014-05-05 Guided bone regeneration membrane and manufacturing method thereof
US16/119,601 US10159737B1 (en) 2007-09-06 2018-08-31 Guided bone regeneration membrane and manufacturing method thereof
US16/227,582 US10814000B2 (en) 2007-09-06 2018-12-20 Guided bone regeneration membrane and manufacturing method thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007231621A JP5179124B2 (en) 2007-09-06 2007-09-06 Bone regeneration inducing membrane and method for producing the same
JP2007-231621 2007-09-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/592,072 Continuation-In-Part US20120315319A1 (en) 2007-09-06 2012-08-22 Guided bone regeneration membrane and manufacturing method thereof

Publications (1)

Publication Number Publication Date
US20100119564A1 true US20100119564A1 (en) 2010-05-13

Family

ID=40556262

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/591,258 Abandoned US20100119564A1 (en) 2007-09-06 2009-11-13 Guided bone regeneration membrane and manufacturing method thereof
US13/592,072 Abandoned US20120315319A1 (en) 2007-09-06 2012-08-22 Guided bone regeneration membrane and manufacturing method thereof
US14/270,137 Active 2030-01-25 US10092650B2 (en) 2007-09-06 2014-05-05 Guided bone regeneration membrane and manufacturing method thereof
US16/119,601 Active US10159737B1 (en) 2007-09-06 2018-08-31 Guided bone regeneration membrane and manufacturing method thereof
US16/227,582 Active 2029-12-29 US10814000B2 (en) 2007-09-06 2018-12-20 Guided bone regeneration membrane and manufacturing method thereof

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/592,072 Abandoned US20120315319A1 (en) 2007-09-06 2012-08-22 Guided bone regeneration membrane and manufacturing method thereof
US14/270,137 Active 2030-01-25 US10092650B2 (en) 2007-09-06 2014-05-05 Guided bone regeneration membrane and manufacturing method thereof
US16/119,601 Active US10159737B1 (en) 2007-09-06 2018-08-31 Guided bone regeneration membrane and manufacturing method thereof
US16/227,582 Active 2029-12-29 US10814000B2 (en) 2007-09-06 2018-12-20 Guided bone regeneration membrane and manufacturing method thereof

Country Status (2)

Country Link
US (5) US20100119564A1 (en)
JP (1) JP5179124B2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103298496A (en) * 2010-07-30 2013-09-11 学校法人近畿大学 Hard tissue regeneration material and hard tissue regeneration method
US20140315149A1 (en) * 2011-12-05 2014-10-23 Hitachi Chemical Company, Ltd. Membrane for inducing regeneration of bone/tissue, and method for producing same
AT516116A1 (en) * 2014-08-05 2016-02-15 Dietmar Dr Sonnleitner Method for producing a multilayer film
EP3020424A4 (en) * 2013-07-09 2016-05-18 Nat Univ Corp Nagoya Inst Tech Bone defect filling material, and production method therefor
US20170246356A1 (en) * 2014-12-26 2017-08-31 Orahn Preiss-Bloom Continuous-fiber reinforced biocomposite medical implants
US9765459B2 (en) 2011-06-24 2017-09-19 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US9827755B2 (en) 2011-06-23 2017-11-28 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US9827696B2 (en) 2011-06-17 2017-11-28 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US10369769B2 (en) 2011-06-23 2019-08-06 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
US10869708B2 (en) 2014-09-07 2020-12-22 Ossio, Ltd. Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
US10869954B2 (en) 2016-03-07 2020-12-22 Ossio, Ltd. Surface treated biocomposite material, medical implants comprising same and methods of treatment thereof
US10888409B2 (en) 2010-06-17 2021-01-12 Washington University Biomedical patches with aligned fibers
CN113456885A (en) * 2021-05-28 2021-10-01 浙江大学 Gradient material for promoting repair of cartilage calcified layer and preparation method thereof
US11173234B2 (en) 2012-09-21 2021-11-16 Washington University Biomedical patches with spatially arranged fibers
US11224677B2 (en) 2016-05-12 2022-01-18 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US11369473B2 (en) 2019-04-08 2022-06-28 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
CN114960037A (en) * 2022-06-17 2022-08-30 遵义医科大学附属口腔医院 PCL-PEG electrostatic spinning nanofiber membrane and preparation method and application thereof
US11491264B2 (en) 2016-06-27 2022-11-08 Ossio Ltd. Fiber reinforced biocomposite medical implants with high mineral content
US11779683B2 (en) 2019-04-08 2023-10-10 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
WO2024050502A3 (en) * 2022-09-01 2024-04-25 MediCarbone, Inc. Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5179124B2 (en) * 2007-09-06 2013-04-10 矢橋工業株式会社 Bone regeneration inducing membrane and method for producing the same
US8853298B2 (en) 2009-07-10 2014-10-07 Nagoya Institute Of Technology Fiber wadding for filling bone defects
JP2011015865A (en) * 2009-07-10 2011-01-27 Nagoya Institute Of Technology Material for filling bone defect and production method thereof
JP5594815B2 (en) * 2009-09-10 2014-09-24 国立大学法人 名古屋工業大学 Bone regeneration inducing membrane and method for producing the same
JP2011212039A (en) * 2010-03-31 2011-10-27 Nagoya Institute Of Technology Material for filling bone defect and method of producing the same
JP5783554B2 (en) * 2011-03-15 2015-09-24 国立大学法人 名古屋工業大学 Manufacturing method of bone filler
JP2013106721A (en) 2011-11-18 2013-06-06 Fujifilm Corp Member for use in tissue regeneration, method for forming the same, and ink
ES2497240B1 (en) 2012-12-24 2015-07-20 Servicio Andaluz De Salud Resorbable membrane for guided bone regeneration
CN103394131B (en) * 2013-07-26 2014-07-16 宁夏医科大学 Novel double-layered composite transmitting tissue regeneration membrane and preparation method thereof
US10213239B2 (en) 2013-09-02 2019-02-26 Fukushima Medical University Porous plate for medical use and manufacturing method of porous plate for medical use
CN103585678B (en) * 2013-11-14 2015-05-13 中山大学 Casein-calcium carbonate microsphere modified polylactic acid membrane material as well as preparation method and application thereof
US9826668B2 (en) * 2013-12-31 2017-11-21 Amogreentech Co., Ltd. Composite sheet and portable terminal having same
UA123157C2 (en) * 2016-04-28 2021-02-24 Нешнл Юніверсіті Корпорейшн Нагоя Інстітьют Оф Текнолоджи Method for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
JP7220852B2 (en) * 2017-06-23 2023-02-13 帝人メディカルテクノロジー株式会社 Membrane for GBR
JP6475799B2 (en) * 2017-08-24 2019-02-27 ワシントン・ユニバーシティWashington University Medical patch with spatially arranged fibers
CN110180013A (en) * 2019-05-31 2019-08-30 上海纳米技术及应用国家工程研究中心有限公司 Overlay film type medical burn prevents adhesion the preparation method and products thereof and application of type gauze bandage
JP7253110B2 (en) 2020-06-21 2023-04-05 Orthorebirth株式会社 Osteoinductive bone regeneration material and method for producing the same
CN113318280B (en) * 2021-04-09 2022-06-21 南通大学 Bone regeneration superfine fiber membrane and preparation method thereof
CN113398338B (en) * 2021-06-30 2022-08-09 华东理工大学 Double-layer repairing film for guiding tissue regeneration and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676699A (en) * 1990-09-10 1997-10-14 Laboratorium fur experimentalle Chirurgie, Forschungsinstitut Bone regeneration membrane
US20020177903A1 (en) * 1997-10-10 2002-11-28 Peter Geistlich Membrane for use in guided tissue regeneration
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3392099B2 (en) * 2000-03-03 2003-03-31 日鉄鉱業株式会社 Method for producing silica-calcium carbonate composite particles, and composition or structure containing the particles
JP5131724B2 (en) * 2006-10-19 2013-01-30 矢橋工業株式会社 Silicon-eluting calcium carbonate and method for producing the same
JP5131736B2 (en) * 2007-05-08 2013-01-30 矢橋工業株式会社 Method for producing silicon-eluting vaterite
US20090028921A1 (en) * 2007-06-18 2009-01-29 New Jersey Institute Of Technology Electrospun Ceramic-Polymer Composite As A Scaffold For Tissue Repair
JP5179124B2 (en) * 2007-09-06 2013-04-10 矢橋工業株式会社 Bone regeneration inducing membrane and method for producing the same
US8853298B2 (en) * 2009-07-10 2014-10-07 Nagoya Institute Of Technology Fiber wadding for filling bone defects

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5676699A (en) * 1990-09-10 1997-10-14 Laboratorium fur experimentalle Chirurgie, Forschungsinstitut Bone regeneration membrane
US20020177903A1 (en) * 1997-10-10 2002-11-28 Peter Geistlich Membrane for use in guided tissue regeneration
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Fabric, Oxford English Dictionary, available at http://www.oed.com/view/Entry/67394?rskey=KddaHk&result=1&isAdvanced=false&print *
Hotta ("Preparation of poly(lactic acid) microfiber mats containing calcium carbonate particles by an electrospinning method," 11th Sympo. Ceramics in Medicine, Biology and Biomimetics, 0.15 (2007), no.15 on 11/13/2009 IDS) *
Maeda et al (Preparation of poly(L-lactic acid)-polysiloxane-calcium carbonate hybrid membranes for guided bone regeneration, 27 Biomater. 1216 (2006) *

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11471260B2 (en) 2010-06-17 2022-10-18 Washington University Biomedical patches with aligned fibers
US10888409B2 (en) 2010-06-17 2021-01-12 Washington University Biomedical patches with aligned fibers
US11311366B2 (en) 2010-06-17 2022-04-26 Washington University Biomedical patches with aligned fibers
US11000358B2 (en) 2010-06-17 2021-05-11 Washington University Biomedical patches with aligned fibers
US11096772B1 (en) 2010-06-17 2021-08-24 Washington University Biomedical patches with aligned fibers
US11071617B2 (en) 2010-06-17 2021-07-27 Washington University Biomedical patches with aligned fibers
US9205030B2 (en) 2010-07-30 2015-12-08 Kinki University Hard tissue regeneration material and hard tissue regeneration method
CN103298496A (en) * 2010-07-30 2013-09-11 学校法人近畿大学 Hard tissue regeneration material and hard tissue regeneration method
US9827696B2 (en) 2011-06-17 2017-11-28 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US10800073B2 (en) 2011-06-17 2020-10-13 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US11383504B2 (en) 2011-06-23 2022-07-12 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US9827755B2 (en) 2011-06-23 2017-11-28 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US10369769B2 (en) 2011-06-23 2019-08-06 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
US11123965B2 (en) 2011-06-23 2021-09-21 Fiberweb Inc. Vapor-permeable, substantially water-impermeable multilayer article
US10850491B2 (en) 2011-06-23 2020-12-01 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US9765459B2 (en) 2011-06-24 2017-09-19 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US10253439B2 (en) 2011-06-24 2019-04-09 Fiberweb, Llc Vapor-permeable, substantially water-impermeable multilayer article
US11866863B2 (en) 2011-06-24 2024-01-09 Berry Global, Inc. Vapor-permeable, substantially water-impermeable multilayer article
US10900157B2 (en) 2011-06-24 2021-01-26 Berry Global, Inc. Vapor-permeable, substantially water-impermeable multilayer article
US9877808B2 (en) * 2011-12-05 2018-01-30 Hitachi Chemical Company, Ltd. Membrane for inducing regeneration of bone/tissue, and method for producing same
US20140315149A1 (en) * 2011-12-05 2014-10-23 Hitachi Chemical Company, Ltd. Membrane for inducing regeneration of bone/tissue, and method for producing same
US11253635B2 (en) 2012-09-21 2022-02-22 Washington University Three dimensional electrospun biomedical patch for facilitating tissue repair
US11596717B2 (en) 2012-09-21 2023-03-07 Washington University Three dimensional electrospun biomedical patch for facilitating tissue repair
US11173234B2 (en) 2012-09-21 2021-11-16 Washington University Biomedical patches with spatially arranged fibers
EP3275472A1 (en) * 2013-07-09 2018-01-31 National University Corporation Nagoya Institute of Technology Bone defect filling material, and production method therefor
AU2014288389B2 (en) * 2013-07-09 2017-07-13 National University Corporation Nagoya Institute Of Technology Bone defect filling material, and production method therefor
EP3020424A4 (en) * 2013-07-09 2016-05-18 Nat Univ Corp Nagoya Inst Tech Bone defect filling material, and production method therefor
US10624747B2 (en) 2014-08-05 2020-04-21 Dietmar SONNLEITNER Method for producing a multilayer film
AT516116A1 (en) * 2014-08-05 2016-02-15 Dietmar Dr Sonnleitner Method for producing a multilayer film
AT516116B1 (en) * 2014-08-05 2016-05-15 Dietmar Dr Sonnleitner Method for producing a multilayer film
US11678923B2 (en) 2014-09-07 2023-06-20 Ossio, Ltd. Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
US10869708B2 (en) 2014-09-07 2020-12-22 Ossio, Ltd. Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
US11730866B2 (en) 2014-12-26 2023-08-22 Ossio, Ltd. Continuous-fiber reinforced biocomposite medical implants
US20170246356A1 (en) * 2014-12-26 2017-08-31 Orahn Preiss-Bloom Continuous-fiber reinforced biocomposite medical implants
US10926004B2 (en) * 2014-12-26 2021-02-23 Ossio Ltd. Continuous-fiber reinforced biocomposite medical implants
US10869954B2 (en) 2016-03-07 2020-12-22 Ossio, Ltd. Surface treated biocomposite material, medical implants comprising same and methods of treatment thereof
US11826487B2 (en) 2016-05-12 2023-11-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US11224677B2 (en) 2016-05-12 2022-01-18 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US11491264B2 (en) 2016-06-27 2022-11-08 Ossio Ltd. Fiber reinforced biocomposite medical implants with high mineral content
US11779683B2 (en) 2019-04-08 2023-10-10 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
US11369473B2 (en) 2019-04-08 2022-06-28 Loubert S. Suddaby Extended release immunomodulatory implant to facilitate bone morphogenesis
CN113456885A (en) * 2021-05-28 2021-10-01 浙江大学 Gradient material for promoting repair of cartilage calcified layer and preparation method thereof
CN114960037A (en) * 2022-06-17 2022-08-30 遵义医科大学附属口腔医院 PCL-PEG electrostatic spinning nanofiber membrane and preparation method and application thereof
WO2024050502A3 (en) * 2022-09-01 2024-04-25 MediCarbone, Inc. Methods for creating, inserting, and removing an intramedullary sleeve system for bone treatment and stabilization

Also Published As

Publication number Publication date
US20120315319A1 (en) 2012-12-13
US20180369382A1 (en) 2018-12-27
US10092650B2 (en) 2018-10-09
JP2009061109A (en) 2009-03-26
US10814000B2 (en) 2020-10-27
US20190117774A1 (en) 2019-04-25
JP5179124B2 (en) 2013-04-10
US10159737B1 (en) 2018-12-25
US20140242186A1 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
US10814000B2 (en) Guided bone regeneration membrane and manufacturing method thereof
Wu et al. Biomimetic porous scaffolds for bone tissue engineering
Surmenev et al. Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis–a review
Boccaccini et al. Bioresorbable and bioactive composite materials based on polylactide foams filled with and coated by Bioglass® particles for tissue engineering applications
Liao et al. The degradation of the three layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane in vitro
Liao et al. A three-layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane for guided tissue regeneration
Murugan et al. Development of nanocomposites for bone grafting
Venugopal et al. Applications of polymer nanofibers in biomedicine and biotechnology
EP0987032B1 (en) Ceramic material for osteoinduction comprising micropores in the surface of macropores
US8518123B2 (en) System and method for tissue generation and bone regeneration
EP1385449B1 (en) Biologically-functionalised, metabolically-inductive implant surfaces
Stylios et al. Present status and future potential of enhancing bone healing using nanotechnology
CA2343333A1 (en) A bioabsorbable, layered composite material for guided bone tissue regeneration
Galván‐Chacón et al. Deconvoluting the Bioactivity of Calcium Phosphate‐Based Bone Graft Substitutes: Strategies to Understand the Role of Individual Material Properties
Khang et al. Preparation and characterization of small intestine submucosa powder impregnated poly (L-lactide) scaffolds: the application for tissue engineered bone and cartilage
WO2009156226A2 (en) A silk membrane for bone graft material and a method for manufacture thereof
Gouma et al. Electrospinning for bone tissue engineering
Liao et al. In vitro and in vivo behaviors of the three-layered nanocarbonated hydroxyapatite/collagen/PLGA composite
Hayashi et al. Transformable Carbonate Apatite Chains as a Novel Type of Bone Graft
Leonor et al. Designing biomaterials based on biomineralization for bone repair and regeneration
WO2022220766A1 (en) Hybrid, artificial bone tissue implant absorbing mechanical vibrations, whose architectural structure imitates trabecular bone, allowing the saturation of bone marrow, blood, and nutrients, supporting autological regeneration, which can be used with titanium structures
Thomas et al. Tissue Engineering Systems
Gkioni et al. Biodegradable polymeric/ceramic composite scaffolds to regenerate bone tissue
Bartley Collagen Based Bioactive Electrospun Scaffolds for Bone Tissue Engineering
OZAWA et al. Apatite deposition on several dental biodegradable materials in simulated body fluid

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE O

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KASUGA, TOSHIHIRO;OTA, YOSHIO;WAKITA, TAKASHI;REEL/FRAME:023547/0465

Effective date: 20091109

Owner name: YABASHI INDUSTRIES CO., LTD,JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KASUGA, TOSHIHIRO;OTA, YOSHIO;WAKITA, TAKASHI;REEL/FRAME:023547/0465

Effective date: 20091109

Owner name: YAMAHACHI DENTAL MFG., CO.,JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KASUGA, TOSHIHIRO;OTA, YOSHIO;WAKITA, TAKASHI;REEL/FRAME:023547/0465

Effective date: 20091109

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION